The following is a summary of “Rituximab combined with intravenous immunoglobulin in autoimmune diseases: a systematic review ...

About Immunoglobulin A Nephropathy and APRIL IgA ... 7 Despite supportive care, there is an unmet need for treatments that address the root cause of the condition. Continued research in the ...

PRINCETON, NJ, USA & TOKYO, Japan I March 31, 2025 I Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd.

Intravenous immunoglobulin (IVIG ... IBD—according to a 2023 review and meta-analysis of people for whom other treatments weren’t effective. In the review, IVIg was a safe and effective ...

Takeda Canada Inc. (Takeda) is pleased to announce that Health Canada has expanded the marketing authorization for HyQvia® ...

With an ever increasing number of patients being treated with IVIg for a wide array of immune-mediated disease, it is important that passive antibody transfer is considered when unexpected ...

The cost of pet insurance is small compared to what you will have to pay for treatments and medical care in case of a disease ...